White Paper: Advanced Flow Cytometry – Rapid Analysis for Complex Cell-Based Models

The growing recognition that pre-clinical animal models often provide incomplete or erroneous results, potentially leading to costly late-stage failures for new drug candidates has opened avenues for the use of cell-based assays that more accurately predict the in vivo activity of new therapeutic agents as a practical alternative. Additionally, advances in our understanding of cell biology and the shift from universally applicable small molecule drugs towards precision medicine approaches and biotherapeutics have resulted in a move towards the use of cell-based assays far earlier in the drug discovery workflow.

Traditional cell-based approaches are, however, not designed to handle the far larger sample sets and high throughput screening assays commonly required for early-stage candidate identification.

Download this white paper to learn how advanced flow cytometry addresses these challenges to deal with the demands of modern drug discovery pipelines.

Complete the form to download